ALEC

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Alector Inc

NASDAQ | ALEC

1.15

USD

$0.00

(

0.00%

)

At Close (As of Dec 2, 2025)

$134.26M

Market Cap

-

P/E Ratio

-1.06

EPS

$3.40

52 Week High

$0.87

52 Week Low

HEALTHCARE

Sector

ALEC Chart

Recent Chart
Price Action

ALEC Technicals

Tags:

ALEC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $101M
Total Revenue $101M
Cost Of Revenue $8.8M
Costof Goods And Services Sold $8.8M
Operating Income -$145M
Selling General And Administrative $60M
Research And Development $186M
Operating Expenses $246M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.8M
Income Before Tax -$119M
Income Tax Expense $128K
Interest And Debt Expense -
Net Income From Continuing Operations -$119M
Comprehensive Income Net Of Tax -
Ebit -$145M
Ebitda -$136M
Net Income -$119M

Revenue & Profitability

Earnings Performance

ALEC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $468M
Total Current Assets $425M
Cash And Cash Equivalents At Carrying Value $33M
Cash And Short Term Investments $33M
Inventory -
Current Net Receivables -
Total Non Current Assets $43M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $380M
Other Current Assets $11M
Other Non Current Assets -
Total Liabilities $342M
Total Current Liabilities $125M
Current Accounts Payable $2.2M
Deferred Revenue -
Current Debt -
Short Term Debt $8.8M
Total Non Current Liabilities $216M
Capital Lease Obligations $33M
Long Term Debt $9.4M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $43M
Other Current Liabilities $90M
Other Non Current Liabilities $1.2M
Total Shareholder Equity $127M
Treasury Stock -
Retained Earnings -$829M
Common Stock $9K
Common Stock Shares Outstanding $97M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$230M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $8.8M
Capital Expenditures $1.3M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $107M
Cashflow From Financing $82M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$119M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $101M
Total Revenue $101M
Cost Of Revenue $8.8M
Costof Goods And Services Sold $8.8M
Operating Income -$145M
Selling General And Administrative $60M
Research And Development $186M
Operating Expenses $246M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.8M
Income Before Tax -$119M
Income Tax Expense $128K
Interest And Debt Expense -
Net Income From Continuing Operations -$119M
Comprehensive Income Net Of Tax -
Ebit -$145M
Ebitda -$136M
Net Income -$119M

ALEC News

ALEC Profile

Alector Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Alector, Inc. (ALEC) is a leading clinical-stage biopharmaceutical firm focused on creating breakthrough therapies for neurodegenerative diseases such as Alzheimer's and frontotemporal dementia. The company harnesses its innovative immuno-neurology platform to engage the immune system in revitalizing neuronal health and function. Headquartered in South San Francisco, Alector is committed to advancing the treatment landscape within neurology, showcased by a robust pipeline of differentiated product candidates that hold the potential to significantly alter the course of these challenging conditions.

LPTX
+368.57%
$2.05
PAVS
-92.57%
$0.07
VHAI
0.00%
$0.00
BYND
-2.23%
$1.31
NVDA
+0.66%
$181.12
PLRZ
+130.56%
$7.28
INTC
+8.57%
$43.44
FTEL
+15.00%
$1.38
CMND
-8.89%
$0.13
PLUG
+12.77%
$2.16
ASST
-6.25%
$1.05
IPG
-1.95%
$24.57
BITF
-1.25%
$3.23
ONDS
+12.59%
$8.53
AXDX
-61.36%
$0.03
AAL
+2.18%
$14.26
TSLA
0.00%
$430.14
JSPR
+6.68%
$1.83
CHR
+4.81%
$0.04
BBD
+1.24%
$3.66
ADAP
-15.14%
$0.05
SOFI
+3.80%
$30.13
BMNR
+12.24%
$32.48
F
-1.32%
$12.98
SNAP
-0.52%
$7.64
IREN
-9.30%
$43.98
SOND
-23.45%
$0.12
GOOGL
-1.65%
$314.89
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
MARA
+5.16%
$12.11
ADD
-25.47%
$0.05
BMNU
+21.82%
$7.48
DNN
+3.17%
$2.60
YGMZ
-26.73%
$0.08
NIO
-2.02%
$5.07
WBD
+3.59%
$24.72
SRM
+53.27%
$10.30
ABEV
0.00%
$2.57
CAN
-6.15%
$0.94
ACHR
+4.15%
$7.77
AAPL
+1.09%
$286.21
IVP
-3.95%
$0.12
AMD
-1.79%
$215.81
AMZN
+0.61%
$235.31
BTBT
+3.55%
$2.33
BQ
+29.00%
$2.51
CLSK
+2.34%
$14.41
PFE
-0.13%
$25.23
PLTD
-2.04%
$6.94
SGMO
+4.39%
$0.44
WLGS
-5.57%
$0.04
INHD
-14.77%
$0.14
PLTR
+2.14%
$171.08
EXK
-2.29%
$9.18
MTSR
-0.35%
$70.50
EB
+78.62%
$4.43
BTG
-3.57%
$4.43
MSTR
+6.42%
$182.44
CIFR
-4.60%
$18.78
WULF
-3.36%
$14.78
APLD
+2.83%
$29.01
ITUB
-1.41%
$7.69
BURU
+4.29%
$0.23
MSFT
-1.07%
$486.74
AFMD
-34.94%
$0.18
ASBP
+5.16%
$0.10
RIVN
+1.72%
$17.45
RIG
0.00%
$4.35
GPUS
+8.41%
$0.29
VALE
+0.98%
$12.81
CRWV
+1.03%
$77.85
HOOD
+3.83%
$127.97
BAC
+0.25%
$53.37
CDE
-1.79%
$16.96
KVUE
-1.71%
$16.92
VCIG
-2.84%
$1.02
ALIT
+3.89%
$2.36
NCT
-26.87%
$0.56
GRYP
-10.38%
$1.38
TAOP
+31.30%
$2.81
RGTI
+1.51%
$23.80
HBAN
+0.53%
$16.62
CRCL
-4.99%
$75.94
MODV
-25.22%
$0.43
TMC
+19.37%
$7.50
GRAB
+0.28%
$5.28
STLA
+2.82%
$10.95
RXRX
-5.83%
$4.36
CGC
+0.44%
$1.13
DRCT
-14.94%
$0.10
MRVL
+1.84%
$92.78
BA
+9.79%
$204.72
SOUN
-0.46%
$11.46
IXHL
+10.68%
$0.39
NFLX
+0.45%
$109.62
PCG
-2.99%
$15.36
BTE
-0.93%
$3.19
AG
+1.41%
$15.74
AKTX
-12.18%
$0.35
LPTX
+368.57%
$2.05
PAVS
-92.57%
$0.07
VHAI
0.00%
$0.00
BYND
-2.23%
$1.31
NVDA
+0.66%
$181.12
PLRZ
+130.56%
$7.28
INTC
+8.57%
$43.44
FTEL
+15.00%
$1.38
CMND
-8.89%
$0.13
PLUG
+12.77%
$2.16
ASST
-6.25%
$1.05
IPG
-1.95%
$24.57
BITF
-1.25%
$3.23
ONDS
+12.59%
$8.53
AXDX
-61.36%
$0.03
AAL
+2.18%
$14.26
TSLA
0.00%
$430.14
JSPR
+6.68%
$1.83
CHR
+4.81%
$0.04
BBD
+1.24%
$3.66
ADAP
-15.14%
$0.05
SOFI
+3.80%
$30.13
BMNR
+12.24%
$32.48
F
-1.32%
$12.98
SNAP
-0.52%
$7.64
IREN
-9.30%
$43.98
SOND
-23.45%
$0.12
GOOGL
-1.65%
$314.89
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
MARA
+5.16%
$12.11
ADD
-25.47%
$0.05
BMNU
+21.82%
$7.48
DNN
+3.17%
$2.60
YGMZ
-26.73%
$0.08
NIO
-2.02%
$5.07
WBD
+3.59%
$24.72
SRM
+53.27%
$10.30
ABEV
0.00%
$2.57
CAN
-6.15%
$0.94
ACHR
+4.15%
$7.77
AAPL
+1.09%
$286.21
IVP
-3.95%
$0.12
AMD
-1.79%
$215.81
AMZN
+0.61%
$235.31
BTBT
+3.55%
$2.33
BQ
+29.00%
$2.51
CLSK
+2.34%
$14.41
PFE
-0.13%
$25.23
PLTD
-2.04%
$6.94
SGMO
+4.39%
$0.44
WLGS
-5.57%
$0.04
INHD
-14.77%
$0.14
PLTR
+2.14%
$171.08
EXK
-2.29%
$9.18
MTSR
-0.35%
$70.50
EB
+78.62%
$4.43
BTG
-3.57%
$4.43
MSTR
+6.42%
$182.44
CIFR
-4.60%
$18.78
WULF
-3.36%
$14.78
APLD
+2.83%
$29.01
ITUB
-1.41%
$7.69
BURU
+4.29%
$0.23
MSFT
-1.07%
$486.74
AFMD
-34.94%
$0.18
ASBP
+5.16%
$0.10
RIVN
+1.72%
$17.45
RIG
0.00%
$4.35
GPUS
+8.41%
$0.29
VALE
+0.98%
$12.81
CRWV
+1.03%
$77.85
HOOD
+3.83%
$127.97
BAC
+0.25%
$53.37
CDE
-1.79%
$16.96
KVUE
-1.71%
$16.92
VCIG
-2.84%
$1.02
ALIT
+3.89%
$2.36
NCT
-26.87%
$0.56
GRYP
-10.38%
$1.38
TAOP
+31.30%
$2.81
RGTI
+1.51%
$23.80
HBAN
+0.53%
$16.62
CRCL
-4.99%
$75.94
MODV
-25.22%
$0.43
TMC
+19.37%
$7.50
GRAB
+0.28%
$5.28
STLA
+2.82%
$10.95
RXRX
-5.83%
$4.36
CGC
+0.44%
$1.13
DRCT
-14.94%
$0.10
MRVL
+1.84%
$92.78
BA
+9.79%
$204.72
SOUN
-0.46%
$11.46
IXHL
+10.68%
$0.39
NFLX
+0.45%
$109.62
PCG
-2.99%
$15.36
BTE
-0.93%
$3.19
AG
+1.41%
$15.74
AKTX
-12.18%
$0.35
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.